QRON
Price
$0.14
Change
-$0.00 (-0.00%)
Updated
May 12 closing price
Capitalization
2.44M
RVMD
Price
$39.48
Change
-$0.47 (-1.18%)
Updated
May 14 closing price
Capitalization
7.35B
83 days until earnings call
Ad is loading...

QRON vs RVMD

Header iconQRON vs RVMD Comparison
Open Charts QRON vs RVMDBanner chart's image
Qrons
Price$0.14
Change-$0.00 (-0.00%)
Volume$5K
Capitalization2.44M
Revolution Medicines
Price$39.48
Change-$0.47 (-1.18%)
Volume$1.33M
Capitalization7.35B
QRON vs RVMD Comparison Chart
Loading...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
QRON vs. RVMD commentary
May 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QRON is a Hold and RVMD is a Hold.

Ad is loading...
COMPARISON
Comparison
May 15, 2025
Stock price -- (QRON: $0.14 vs. RVMD: $39.48)
Brand notoriety: QRON and RVMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: QRON: 77% vs. RVMD: 53%
Market capitalization -- QRON: $2.44M vs. RVMD: $7.35B
QRON [@Biotechnology] is valued at $2.44M. RVMD’s [@Biotechnology] market capitalization is $7.35B. The market cap for tickers in the [@Biotechnology] industry ranges from $289.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QRON’s FA Score shows that 1 FA rating(s) are green whileRVMD’s FA Score has 1 green FA rating(s).

  • QRON’s FA Score: 1 green, 4 red.
  • RVMD’s FA Score: 1 green, 4 red.
According to our system of comparison, RVMD is a better buy in the long-term than QRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RVMD’s TA Score shows that 5 TA indicator(s) are bullish.

  • RVMD’s TA Score: 5 bullish, 5 bearish.

Price Growth

QRON (@Biotechnology) experienced а -9.33% price change this week, while RVMD (@Biotechnology) price change was +4.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.30%. For the same industry, the average monthly price growth was +5.09%, and the average quarterly price growth was -6.29%.

Reported Earning Dates

QRON is expected to report earnings on May 15, 2023.

RVMD is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-0.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($7.35B) has a higher market cap than QRON($2.44M). RVMD YTD gains are higher at: -9.739 vs. QRON (-25.679). QRON has higher annual earnings (EBITDA): -343.38K vs. RVMD (-776.65M). RVMD has more cash in the bank: 2.1B vs. QRON (2.14K). QRON has less debt than RVMD: QRON (382K) vs RVMD (134M). QRON (0) and RVMD (0) have equivalent revenues.
QRONRVMDQRON / RVMD
Capitalization2.44M7.35B0%
EBITDA-343.38K-776.65M0%
Gain YTD-25.679-9.739264%
P/E RatioN/AN/A-
Revenue00-
Total Cash2.14K2.1B0%
Total Debt382K134M0%
FUNDAMENTALS RATINGS
QRON: Fundamental Ratings
QRON
OUTLOOK RATING
1..100
91
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RVMD
RSI
ODDS (%)
Bearish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
72%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SSGFX54.93N/A
N/A
Saturna Growth
FCVFX31.38N/A
N/A
Fidelity Advisor Value C
MWOBX48.92N/A
N/A
MFS Global Growth B
HNACX114.48N/A
N/A
Harbor Capital Appreciation Retirement
PLKGX76.68-0.41
-0.53%
Putnam Small Cap Growth R6